Other Streetwise ReportsThe Gold Report The Energy Report The Life Sciences Report The Mining Report
Today's Featured Company
ImmunoCellular Therapeutics Ltd.: (IMUC:NYSE.MKT) ImmunoCellular Therapeutics Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The company has concluded a Phase 2 trial of its lead product candidate, ICT-107, a dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma stem cells. More >
Streetwise Expert Interviews
Exceptional Management and Disruptive Products Top the Investment Checklist for Vista Partners' Ross Silver
Investing in micro- and small-cap biotech companies carries great risk, but for investors who take the time to dig out the value proposition, the upside can be phenomenal. Enter Ross Silver of Vista Partners, who publishes research and owns many of the stocks he writes about. In this interview with The Life Sciences Report, Silver puts two biotech names on the table for investors to consider.(5/20/15) More >
An immunotherapy revolution is rocking biotechnology, and investors are searching for just the right way to play the new trend. John McCamant, editor of the Medical Technology Stock Letter, has performed some serious diligence, and discusses a handful of names with a range of market caps and the potential to achieve significant investment upside. (5/12/15) More >
It's been four months since The Life Sciences Report's 2015 Small-Cap Biotech Watchlist was announced at the Biotech Showcase in San Francisco. The year is off to a bumpy start, though the rough ride is not predicated, necessarily, on individual company performance. Read on for highlights of the Watchlist's Q1/15 performance. (5/13/15) More >
Learn More About Companies in This Issue
|Alliance for Regenerative Medicine|
BrainStorm Cell Therapeutics Inc.
RepliCel Life Sciences Inc.
|Nobilis Health Corp.|